American Well Corporation (AMWL)
NYSE: AMWL · Real-Time Price · USD
5.59
+0.13 (2.38%)
Mar 9, 2026, 3:36 PM EDT - Market open

Company Description

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally.

The company offers Amwell Platform, a cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings; Amwell Carepoint, a device enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings; Amwell Converge, a platform and wraparound services of digital care into the in-person, automated, and virtual care settings; and Behavioral Health, a platform that offer students and faculty the right level of care.

It also provides specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care for patients and members; Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, lactation counseling, and nutrition services.

Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services.

The company sells its products through field sales professionals, channel partners, and value-added resellers.

It serves providers, payers, and the government, as well as the higher education sector. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.

American Well Corporation
American Well logo
Country United States
Founded 2006
IPO Date Sep 17, 2020
Industry Health Information Services
Sector Healthcare
Employees 562
CEO Ido Schoenberg

Contact Details

Address:
75 State Street, 26th Floor
Boston, Massachusetts 02109
United States
Phone 617 204 3500
Website business.amwell.com

Stock Details

Ticker Symbol AMWL
Exchange NYSE
Stock Type Common Stock
Share Class Class A Shares
Fiscal Year January - December
Reporting Currency USD
IPO Price $18.00
CIK Code 0001393584
CUSIP Number 03044L204
ISIN Number US03044L2043
SIC Code 7389

Key Executives

Name Position
Dr. Ido Schoenberg M.D. Chairman and Chief Executive Officer
Dr. Roy Schoenberg M.D., M.P.H. Executive Vice Chairman
Mark J. Hirschhorn CPA Executive Vice President, Chief Operating Officer and Chief Financial Officer
Phyllis I. Gotlib President of Amwell International
Paul Francis McNeice Vice President of Accounting
Dan Zamansky Chief Product and Technology Officer
Sue Dooley Head of Investor Relations
Anna Nesterova Head of Legal
Michael Miller Senior Vice President and Chief Sales Officer
Dr. Cynthia Horner FAAFP, M.D. Chief Medical Officer and President of Amwell Medical Group

Latest SEC Filings

Date Type Title
Mar 4, 2026 S-8 Securities to be offered to employees in employee benefit plans
Mar 2, 2026 144 Filing
Mar 2, 2026 144 Filing
Mar 2, 2026 144 Filing
Feb 13, 2026 SCHEDULE 13G/A Filing
Feb 12, 2026 10-K Annual Report
Feb 12, 2026 SCHEDULE 13G/A Filing
Feb 12, 2026 8-K Current Report
Jan 26, 2026 SCHEDULE 13G Filing
Jan 8, 2026 8-K Current Report